In patent dispute between Teva, Amneal, professors file amicus brief with US appeals court
MLex Summary: Listing by Teva Branded Pharmaceutical Products R&D of five ProAir HFA inhaler patents in the US Food and Drug Administration's Orange Book of approved drugs represents a "classic case...To view the full article, register now.
Already a subscriber? Click here to view full article